| Patient | Jane Austen |
|---|---|
| Date of birth | 1775-12-16 |
| Identifiers | MRN HR-EN014-SYN-TD; SSN (made up) 000-14-6317 |
| Document date | 1816-03-19 |
| Author | Harriet Pemberton-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-day review, seen the same morning by endocrinology for a cosyntropin stimulation test. [S]
Ms. Austen returns three days after her first visit and was seen this morning by Dr. Varga-Whitlock of endocrinology, who performed a cosyntropin stimulation test. Since her last visit she has salted her food freely and has felt about the same: tired, with little appetite, a bout of nausea each morning, and lightheadedness when she stands quickly. She vomited once two days ago but kept fluids down afterwards. She has had no fainting, confusion, or severe abdominal pain. Her back still aches by the end of the day. She has brought a page of notes on how she has felt each day since the winter. [S]
| Element | Detail |
|---|---|
| Symptoms | Unchanged tiredness and poor appetite; morning nausea; one vomit two days ago; lightheaded on standing |
| Weight | 51.8 kg, from 52.0 |
| Testing today | 8 am cortisol and ACTH, then cosyntropin 250 mcg with cortisol at 30 and 60 minutes; renin, aldosterone, LDH and electrolytes; chest X-ray |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; poor appetite; feels feverish some evenings; no drenching night sweats |
| Cardiovascular | Positive | Lightheaded on standing quickly; no fainting or palpitations |
| Gastrointestinal | Positive | Morning nausea; one vomit two days ago; salt craving; no abdominal pain or diarrhea |
| Musculoskeletal | Positive | Low back ache by evening |
| Hematologic and lymphatic | Negative | No lumps in the neck, armpits or groin; no itching |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking | One tablet by mouth on waking | Oral route | 1816-03-19 | active | S |
| Hydrocortisone 5 mg oral tablet, one tablet by mouth at 2 pm | One tablet by mouth at 2 pm | Oral route | 1816-03-19 | active | S |
| Fludrocortisone 0.1 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1816-03-19 | active | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 1816-03-19 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1816-03-19 | Body height | 170 | cm | S |
| 1816-03-19 | Body weight | 51.8 | kg | S |
| 1816-03-19 | Body mass index (BMI) [Ratio] | 17.9 | kg/m2 | S |
| 1816-03-19 | Systolic blood pressure | 96 | mm[Hg] | S |
| 1816-03-19 | Diastolic blood pressure | 60 | mm[Hg] | S |
| 1816-03-19 | Heart rate | 94 | /min | S |
| 1816-03-19 | Respiratory rate | 16 | /min | S |
| 1816-03-19 | Body temperature | 37.3 | Cel | S |
| 1816-03-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1816-03-19 | Cortisol [Mass/volume] in Serum or Plasma | 2.6 | ug/dL | 8 am: 5 to 23 ug/dL | Low | S |
| 1816-03-19 | Corticotropin [Mass/volume] in Plasma | 548 | pg/mL | 7.2-63 pg/mL | High | S |
| 1816-03-19 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid | 3.4 | ug/dL | Peak of 18 ug/dL or more excludes adrenal insufficiency (about 14 to 15 ug/dL on newer assays) | Low | S |
| 1816-03-19 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid | 3.9 | ug/dL | Peak of 18 ug/dL or more excludes adrenal insufficiency (about 14 to 15 ug/dL on newer assays) | Low | S |
| 1816-03-19 | Renin [Enzymatic activity/volume] in Plasma | 16.2 | ng/mL/h | Upright, mid-morning: 0.6 to 4.3 ng/mL/h | High | S |
| 1816-03-19 | Aldosterone [Mass/volume] in Serum or Plasma | 1.8 | ng/dL | Upright, mid-morning: 4 to 31 ng/dL | Low | S |
| 1816-03-19 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 172 | U/L | 140-280 U/L | Normal | S |
| 1816-03-19 | Sodium [Moles/volume] in Serum or Plasma | 132 | mmol/L | 135-145 mmol/L | Low | S |
| 1816-03-19 | Potassium [Moles/volume] in Serum or Plasma | 5.3 | mmol/L | 3.5-5.1 mmol/L | High | S |
Vital signs recorded on 1816-03-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin and tired but alert; weight 51.8 kg |
| Blood pressure lying and standing | 100/64 lying, pulse 88; 86/56 after three minutes standing, pulse 106: a postural drop of 14 mmHg systolic |
| Skin and mouth | Diffuse bronze darkening of the face and the backs of the hands, deeper in the palmar creases, knuckles and an old scar on the forearm, with patches of brown pigment on the gums and inside the cheeks; pale lips |
| Lymph nodes | No cervical, supraclavicular, axillary or inguinal nodes |
| Abdomen | Soft and non-tender; no enlarged liver or spleen |
| Mucous membranes | Slightly dry |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three months of increasing tiredness, loss of 5 kg, darkening of the skin, nausea with bouts of vomiting, low back ache, salt craving and lightheadedness on standing, with low sodium, high potassium and raised eosinophils; adrenal insufficiency suspected and urgent endocrinology testing booked | resolved | confirmed | R53.83 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; its timing echoes the documented break in her health (D). |
| Primary adrenal insufficiency (Addison's disease): no cortisol response to cosyntropin with a markedly raised ACTH, and mineralocorticoid deficiency with raised renin and low aldosterone; on hydrocortisone and fludrocortisone; synthetic modern diagnosis chosen for a historical illness whose cause is disputed | active | confirmed | E27.1 | S — Synthetic modern diagnosis; the historical cause of her illness remains undetermined (R, disputed). |
| Mild normocytic anemia (hemoglobin 11.4 g/dL) with normal ferritin, vitamin B12 and folate | active | confirmed | D64.9 | S — Synthetic finding at intake; it recovers on replacement. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Diagnosis: 8 am cortisol and ACTH with a cosyntropin stimulation test | Once, at diagnosis | Completed today | Cortisol 2.6 ug/dL with ACTH 548 pg/mL; cortisol 3.4 ug/dL at 30 minutes and 3.9 ug/dL at 60 minutes after cosyntropin: confirmed |
| Examination | Glucocorticoid dose: weight, energy, appetite, skin pigmentation, and signs of under- or over-replacement | Every visit | Completed today | Weight 51.8 kg; tired, poor appetite, marked pigmentation: untreated; replacement started today |
| Examination | Blood pressure lying and standing | Every visit | Completed today | 100/64 lying, 86/56 standing: postural drop of 14 mmHg |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | Before treatment, after any fludrocortisone change, then at least yearly | Completed today | Sodium 132 and potassium 5.3 mmol/L before the first dose; salt craving |
| Laboratory | Plasma renin activity (with aldosterone at diagnosis) | At diagnosis; after any fludrocortisone change; then at least yearly, aiming for the upper normal range | Completed today | Renin 16.2 ng/mL/h with aldosterone 1.8 ng/dL before treatment: mineralocorticoid deficiency; fludrocortisone started |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Kit prescribed and the injection taught on a trainer; written rules given; card issued; medical ID to be ordered |
| Laboratory | Cause: 21-hydroxylase antibodies; adrenal CT and tuberculosis testing if negative | Once, at diagnosis | Ordered | Antibodies to be drawn at the two-week visit; adrenal CT and tuberculosis testing only if negative |
| Imaging | Differential for lymphoma: weight, fevers and night sweats, lymph nodes and spleen, LDH, chest X-ray | At diagnosis, then each visit until symptoms and weight have recovered on replacement | Completed today | No nodes, liver or spleen enlargement; LDH 172 U/L; chest X-ray today normal, with no hilar or mediastinal widening and no sign of old or active tuberculosis |
| Laboratory | Associated autoimmune disease: TSH, vitamin B12, A1c, celiac serology, and menstrual history | At diagnosis, then TSH and the others yearly or with symptoms; FSH if periods change | Ordered | TSH 3.6 mIU/L and vitamin B12 486 pg/mL at the first visit; A1c and celiac serology at the two-week visit; periods regular |
| Laboratory | Blood count for the normocytic anemia (with ferritin, vitamin B12 and folate at work-up) | Work-up at diagnosis; repeat after the underlying cause is treated (CMID); stop once normal | Up to date | Hemoglobin 11.4 g/dL with normal ferritin, vitamin B12 and folate at the first visit; repeat in two weeks |
| Referral | Endocrinology review | At diagnosis, then at least yearly | Completed today | Seen by Dr. Varga-Whitlock this morning |
Goal progress:
Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026); American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023)
Follow-up: Two-week visit with electrolytes, blood count, 21-hydroxylase antibodies, A1c and celiac serology. Inject and call 911 for vomiting, fainting or confusion; follow the sick-day rules for any fever. Next scheduled visit 1816-04-02: two-week review after starting replacement: electrolytes, cause, and autoimmune screening. [S]